These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 29404743)

  • 1. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
    Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.
    Nigro G; Capretti I; Manganello AM; Best AM; Adler SP
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):168-71. PubMed ID: 24660895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
    J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization during pregnancy for congenital cytomegalovirus infection.
    Nigro G; Adler SP; La Torre R; Best AM;
    N Engl J Med; 2005 Sep; 353(13):1350-62. PubMed ID: 16192480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy.
    Kekkou K; Kavatha D; Karalexi M; Galani L; Dimopoulou D; Papaevangelou V; Antoniadou A
    J Matern Fetal Neonatal Med; 2021 Jun; 34(12):2025-2029. PubMed ID: 31401915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
    Revello MG; Lazzarotto T; Guerra B; Spinillo A; Ferrazzi E; Kustermann A; Guaschino S; Vergani P; Todros T; Frusca T; Arossa A; Furione M; Rognoni V; Rizzo N; Gabrielli L; Klersy C; Gerna G;
    N Engl J Med; 2014 Apr; 370(14):1316-26. PubMed ID: 24693891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
    Yinon Y; Farine D; Yudin MH
    Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose Cytomegalovirus (CMV) Hyperimmune Globulin and Maternal CMV DNAemia Independently Predict Infant Outcome in Pregnant Women With a Primary CMV Infection.
    Nigro G; Adler SP;
    Clin Infect Dis; 2020 Sep; 71(6):1491-1498. PubMed ID: 31628849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
    Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on CMV congenital infection.
    Coll O; Benoist G; Ville Y; Weisman LE; Botet F; Anceschi MM; Greenough A; Gibbs RS; Carbonell-Estrany X;
    J Perinat Med; 2009; 37(5):433-45. PubMed ID: 19673682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.
    Karofylakis E; Thomas K; Kavatha D; Galani L; Tsiodras S; Giamarellou H; Papaevangelou V; Antoniadou A
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome.
    Lazzarotto T; Gabrielli L; Foschini MP; Lanari M; Guerra B; Eusebi V; Landini MP
    Pediatrics; 2003 Aug; 112(2):e153-7. PubMed ID: 12897321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.
    Enders G; Daiminger A; Bäder U; Exler S; Enders M
    J Clin Virol; 2011 Nov; 52(3):244-6. PubMed ID: 21820954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening, prevention, and treatment of congenital cytomegalovirus.
    Johnson J; Anderson B
    Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.
    Naing ZW; Scott GM; Shand A; Hamilton ST; van Zuylen WJ; Basha J; Hall B; Craig ME; Rawlinson WD
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):9-18. PubMed ID: 26391432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.